CVS
CVS HEALTH Corp
NYSE · Healthcare · Medical - Healthcare Plans · US
$88.84
−1.58%Sep 18, 2026, 21:30 UTC
Ascension agreed to sell its ownership stake in Arizona Medicaid insurer Mercy Care to CVS Health-owned Aetna, pending regulatory approval.
Source:Sep 18, 2026, 15:45 UTC
Omnicare reached a $440 million settlement with the U.S. Department of Justice to resolve an improper billing case, requiring CVS to pay $130 million upfront and cover the remaining $310 million if Omnicare fails to pay by March 2028.
Source:Sep 18, 2026, 15:45 UTC
CVS Omnicare, the long-term care pharmacy subsidiary of CVS Health, received court approval from Judge Stacey G. C. Jernigan of the U.S. Bankruptcy Court for the Northern District of Texas for its Chapter 11 wind-down bankruptcy plan after selling its business operations for $250 million.
Source:Sep 15, 2026, 15:30 UTC
Kenvue, the maker of Tylenol, along with pharmacy chains Walgreens, CVS, Walmart and Target, asked the Second U.S. Circuit Court of Appeals to reconsider its July 13, 2026 ruling that revived more than 500 autism-related acetaminophen lawsuits.
Source:Sep 14, 2026, 19:45 UTC
Texas Financial Crimes Intelligence Center and local police arrested four suspects — Deshun Zheng, Minjiang Chen, Xiaoqiang Yu and Minlin Chen — in Sugar Land and Tyler, Texas, for a multi-state gift card tampering ring tied to more than $100,000 in potential losses.
Sep 14, 2026, 11:45 UTC
Taiwan-listed commercial display rack maker Yuqing-KY (6957) plans to launch three-shift production to expand capacity in response to rush orders from North American retailers.
Source:Sep 1, 2026, 23:59 UTC
CVS added JPMorgan's data and analytics chief to its board, while Glenview Capital Management's CEO is leaving.
Aug 26, 2026, 13:59 UTC
Onos Health raised $17 million in Series A funding led by Costanoa, with CVS Health Ventures and Flare Capital Partners participating, less than a year after its previous round.
Aug 22, 2026, 07:07 UTC
Allworth Financial LP acquired a new stake in CVS Health Corporation, purchasing 33,215 shares valued at approximately $3.44 million, as disclosed in a recent SEC filing.
Source:Aug 17, 2026, 20:15 UTC
CVS Health announced the appointment of Teresa Heitsenrether to its Board of Directors and the departure of Larry Robbins from the Board on August 17, 2026.
Source:Aug 17, 2026, 08:43 UTC
Fielder Capital Group LLC acquired a new position in CVS Health Corporation, purchasing 5,972 shares valued at approximately $618,000 during the quarter, as disclosed in a recent SEC filing.
Source:Aug 5, 2026, 10:25 UTC
CVS Health announced a collaboration with Eli Lilly and Company to provide eligible Zepbound and Foundayo patients an additional access point at CVS Pharmacy through the CVS Health app, enhancing its direct-to-consumer weight management offerings for GLP-1 medications.
Source:Aug 5, 2026, 00:00 UTC
CVS Health Corp reported second quarter 2026 total revenues of $106.1 billion, GAAP diluted EPS of $2.31, and adjusted EPS of $2.58, and provided full year 2026 guidance including adjusted EPS of $7.90-$8.10 and cash flow from operations of at least $11.5 billion.
Jul 31, 2026, 16:30 UTC
CVS paid more than $70 million in fines after Department of Justice investigations into opioid-related conduct across 11 states, including Rhode Island, Connecticut, and Massachusetts.
Source:Jul 31, 2026, 16:30 UTC
CVS has been sued by thousands of cities, counties, states, and tribal governments for its role in the opioid crisis, and in 2022 paid $5 billion to settle those lawsuits, without admitting liability.
Source:Jul 30, 2026, 16:20 UTC
A federal appeals court revived portions of nationwide litigation against drugmakers and retailers over false advertising claims regarding oral phenylephrine decongestants labeled 'maximum strength'.
Source:Jul 21, 2026, 13:00 UTC
CVS Health announced that common prescription medications for dogs and cats are now available at all CVS Pharmacy locations nationwide.
Jul 17, 2026, 16:00 UTC
CVS Health opened its first pharmacy-focused CVS Pharmacy location in Houston.
Source:Jul 16, 2026, 17:55 UTC
The Federal Trade Commission announced a multibillion-dollar settlement with CVS Caremark that is expected to lower prescription costs for consumers by changing how certain drug rebates are handled.
Source:Jul 16, 2026, 14:00 UTC
North Carolina State Health Plan board selected Blue Cross Blue Shield of North Carolina as its new third-party administrator and pharmacy benefits manager, replacing Aetna and CVS Caremark, effective January 1, 2028.
Source:Jul 15, 2026, 09:00 UTC
U.S. Senators Richard Blumenthal and Josh Hawley requested internal records and detailed information from UnitedHealth Group, Humana, and CVS Health regarding their use of artificial intelligence to deny rehabilitative care in Medicare Advantage plans.
Source:Jul 12, 2026, 18:00 UTC
CVS Health sued in federal court to block Tennessee's new law aimed at preventing health insurers from managing prescription benefits and running pharmacies.
Source:Jul 10, 2026, 23:59 UTC
Blue Cross Blue Shield of North Carolina (BCBSNC) was awarded the Third-Party Administrator (TPA) and Pharmacy Benefit Manager (PBM) contracts by the North Carolina State Health Plan Board of Trustees, effective January 2028.
Source:Jun 28, 2026, 23:59 UTC
At least a dozen U.S. states passed laws in 2025 to regulate pharmacy benefit managers, including limiting compensation, setting minimum payments to pharmacists, and requiring more disclosure.
Source:Jun 28, 2026, 23:59 UTC
CVS Health Corp. filed a federal lawsuit to challenge a Tennessee law that will bar pharmacy benefit managers from operating retail pharmacies as of July 1, 2028.
Source:Jun 25, 2026, 14:04 UTC
CVS Caremark declined to add ARS Pharmaceuticals' epinephrine spray Neffy to its formulary.
Source:
Page 1Next →